V
Vincent W. T. Lam
Researcher at Westmead Hospital
Publications - 102
Citations - 3011
Vincent W. T. Lam is an academic researcher from Westmead Hospital. The author has contributed to research in topics: Internal medicine & Hepatectomy. The author has an hindex of 28, co-authored 83 publications receiving 2415 citations. Previous affiliations of Vincent W. T. Lam include Liverpool Hospital & University of Hong Kong.
Papers
More filters
Journal ArticleDOI
A systematic review of two‐stage hepatectomy in patients with initially unresectable colorectal liver metastases
Vincent W. T. Lam,Vincent W. T. Lam,Jerome M. Laurence,Emma L. Johnston,Emma L. Johnston,Michael J. Hollands,Michael J. Hollands,Henry Pleass,Henry Pleass,Arthur J. Richardson,Arthur J. Richardson +10 more
TL;DR: Two-stage hepatectomy is safe and effective in selected patients with initially unresectable CLM and the exact roles of PVE and preoperative and interval chemotherapy are better defined.
Journal ArticleDOI
Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma
Vincent W. T. Lam,Kelvin K. Ng,Kenneth S. H. Chok,Tan To Cheung,Jimmy H. F. Yuen,Helen Tung,Wai-Kuen Tso,Sheung Tat Fan,Ronnie T.P. Poon +8 more
TL;DR: This study demonstrated that tumor size > 2.5 cm was the main risk factor for local recurrence after RFA of hepatocellular carcinoma, and suggested that additional aggressive treatment ofLocal recurrence aimed at complete tumor response improves overall survival of patients.
Journal ArticleDOI
A Systematic Review of Clinical Response and Survival Outcomes of Downsizing Systemic Chemotherapy and Rescue Liver Surgery in Patients with Initially Unresectable Colorectal Liver Metastases
Vincent W. T. Lam,Calista Spiro,Jerome M. Laurence,Jerome M. Laurence,Emma L. Johnston,Emma L. Johnston,Michael J. Hollands,Henry Pleass,Henry Pleass,Arthur J. Richardson,Arthur J. Richardson +10 more
TL;DR: Current evidence suggests that downsizing systematic chemotherapy followed by rescue liver resection is safe and effective for selected patients with initially unresectable CLM.
Journal ArticleDOI
A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
Jerome M. Laurence,Jerome M. Laurence,Jerome M. Laurence,Peter Duy Tran,Kavita Morarji,Guy D. Eslick,Vincent W. T. Lam,Vincent W. T. Lam,Charbel Sandroussi,Charbel Sandroussi +9 more
TL;DR: The meta-analysis found that patients with unresectable pancreatic cancer who underwent neoadjuvant chemoradiotherapy achieved similar survival outcomes to patients with resectable disease, even though only 40% were ultimately resected.
Journal ArticleDOI
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification
Diamantis I. Tsilimigras,Fabio Bagante,Fabio Bagante,Kota Sahara,Dimitrios Moris,J. Madison Hyer,Lu Wu,Francesca Ratti,Hugo Marques,Olivier Soubrane,Anghela Z. Paredes,Vincent W. T. Lam,George A. Poultsides,Irinel Popescu,Sorin Alexandrescu,Guillaume Martel,Aklile Workneh,Alfredo Guglielmi,Thomas J. Hugh,Luca Aldrighetti,Itaru Endo,Timothy M. Pawlik +21 more
TL;DR: Designation into BCLC stage B should not be considered an a priori contraindication to surgery, and surgery provided acceptable long-term outcomes among select patients with B CLC-B HCC.